These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12724497)

  • 1. Reversible dementia due to thalidomide therapy for multiple myeloma.
    Morgan AE; Smith WK; Levenson JL
    N Engl J Med; 2003 May; 348(18):1821-2. PubMed ID: 12724497
    [No Abstract]   [Full Text] [Related]  

  • 2. Leukocytoclastic vasculitis due to thalidomide in multiple myeloma.
    Yildirim ND; Ayer M; Küçükkaya RD; Alpay N; Mete O; Yenerel MN; Yavuz AS; Nalçaci M
    Jpn J Clin Oncol; 2007 Sep; 37(9):704-7. PubMed ID: 17709605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma.
    Rajkumar SV; Witzig TE
    Cancer Treat Rev; 2000 Oct; 26(5):351-62. PubMed ID: 11006136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of thalidomide in the treatment of multiple myeloma.
    Warzocha K; Kraj M; Pogłód R; Szpila T; Mendek-Czajkowska E; Chełstowska M; Tronina RH
    Acta Pol Pharm; 2008; 65(6):771-4. PubMed ID: 19172865
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thalidomide for the treatment of refractory multiple myeloma].
    Kakimoto T; Hattori Y; Okamoto S
    Rinsho Ketsueki; 2002 May; 43(5):345-8. PubMed ID: 12096483
    [No Abstract]   [Full Text] [Related]  

  • 6. High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma.
    Neben K; Moehler T; Egerer G; Kraemer A; Hillengass J; Benner A; Ho AD; Goldschmidt H
    Clin Cancer Res; 2001 Sep; 7(9):2675-81. PubMed ID: 11555579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalidomide and thrombosis.
    Mehta P
    Clin Adv Hematol Oncol; 2003 Aug; 1(8):464-5. PubMed ID: 16258433
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide.
    Witzens M; Moehler T; Neben K; Fruehauf S; Hartschuh W; Ho AD; Goldschmidt H
    Ann Hematol; 2004 Jul; 83(7):467-70. PubMed ID: 14625789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encephalopathy in a patient after long-term treatment with thalidomide.
    Sohlbach K; Heinze S; Shiratori K; Sure U; Pagenstecher A; Neubauer A
    J Clin Oncol; 2006 Oct; 24(30):4942-4. PubMed ID: 17050881
    [No Abstract]   [Full Text] [Related]  

  • 10. Diabetic foot disease in a patient with multiple myeloma receiving thalidomide.
    Pitini V; Arrigo C; Aloi G; Azzarello D; La Gattuta G
    Haematologica; 2002 Feb; 87(2):ELT07. PubMed ID: 11836184
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thalidomide and others: new treatment for myeloma].
    Malphettes M; Fermand JP
    Rev Prat; 2003 Oct; 53(15):1633-5. PubMed ID: 14689905
    [No Abstract]   [Full Text] [Related]  

  • 12. Unstable plasma thalidomide concentration in patients with refractory multiple myeloma.
    Kodama T; Horiuchi R; Tsukamoto N; Nojima Y; Murakami H
    Lab Hematol; 2004; 10(3):132-6. PubMed ID: 15479647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thalidomide treatment in multiple myeloma].
    Hattori Y
    Rinsho Ketsueki; 2003 May; 44(5):302-12. PubMed ID: 12822404
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination of pamidronate and thalidomide in the therapy of treatment-resistant multiple myeloma.
    Ciepłuch H; Baran W; Hellmann A
    Med Sci Monit; 2002 Apr; 8(4):PI31-6. PubMed ID: 11951079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide: present and future in multiple myeloma.
    Hussein MA
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):25-31. PubMed ID: 15757435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathy in multiple myeloma treated with thalidomide: a prospective study.
    Plasmati R; Pastorelli F; Cavo M; Petracci E; Zamagni E; Tosi P; Cangini D; Tacchetti P; Salvi F; Bartolomei I; Michelucci R; Tassinari CA
    Neurology; 2007 Aug; 69(6):573-81. PubMed ID: 17679676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interstitial pneumonitis as an adverse effect of thalidomide].
    Scholte JB; Potjewijd J; Voogt PJ; Custers FL; Jie KS
    Ned Tijdschr Geneeskd; 2009; 153():A452. PubMed ID: 20051154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interstitial pneumonitis as an adverse effect of thalidomide].
    Scholte JB; Potjewijd J; Voogt PJ; Custers FL; Lie KS
    Ned Tijdschr Geneeskd; 2009; 153():A452. PubMed ID: 19785872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide for the treatment of multiple myeloma.
    Hattori Y; Iguchi T
    Congenit Anom (Kyoto); 2004 Sep; 44(3):125-36. PubMed ID: 15327481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two cases of bacterial meningitis accompanied by thalidomide therapy in patients with multiple myeloma: is thalidomide associated with bacterial meningitis?
    Pasa S; Altintas A; Cil T; Ustun C; Bayan K; Danis R; Urakci Z; Tuzun Y; Ayyildiz O
    Int J Infect Dis; 2009 Jan; 13(1):e19-22. PubMed ID: 18621563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.